Development and Implementation of Proton Therapy for Hodgkin Lymphoma: Challenges and Perspectives
Consolidative radiation therapy for early-stage Hodgkin lymphoma (HL) improves progression-free survival. Unfortunately, first-generation techniques, relying on large irradiation fields, were associated with an increased risk of secondary cancers, and of cardiac and lung toxicity. Fortunately, the u...
Main Authors: | Pierre Loap, Ludovic De Marzi, Alfredo Mirandola, Remi Dendale, Alberto Iannalfi, Viviana Vitolo, Amelia Barcellini, Andrea Riccardo Filippi, Barbara Alicja Jereczek-Fossa, Youlia Kirova, Ester Orlandi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3744 |
Similar Items
-
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence
by: Pierre Loap, et al.
Published: (2021-07-01) -
Hadrontherapy for Thymic Epithelial Tumors: Implementation in Clinical Practice
by: Pierre Loap, et al.
Published: (2021-10-01) -
Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?
by: De Sanctis Vitaliana, et al.
Published: (2012-08-01) -
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision
by: Alessandro Vai, et al.
Published: (2022-02-01) -
Estimation of Mediastinal Toxicities after Radiotherapy for Hodgkin Lymphoma—A Normal Tissue Complication Analysis of the HD16/17 Trial by the German Hodgkin Study Group
by: Michael Oertel, et al.
Published: (2024-03-01)